Who owns GALMED PHARMACEUTICALS LTD?
- Ticker: GLMD
- CUSIP Number: m47238148
Tip: Access positions for across all investors
Analyze quarterly positions in Galmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galmed Pharmaceuticals stock
Who bought or sold GALMED PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 51k | $71k | 100% | Sep 2025 |
|
| Morgan Stanley | 34k | $62k | 100% | Jun 2025 |
|
| Two Sigma Investments | 21k | $29k | 100% | Sep 2025 |
|
| UBS Group | 963.00 | $1.3k | -86% | Sep 2025 |
|
| Sontag Advisory | 21.00 | $29.001000 | 100% | Sep 2025 |
|
| TSFG | 17.00 | $0 | 0% | Sep 2025 |
|
| SBI Securities | 16.00 | $22.000000 | -99% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 14.00 | $18.999400 | 0% | Sep 2025 |
|
| Wells Fargo & Company | 9.00 | $11.999700 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 5.00 | $6.000000 | 0% | Sep 2025 |
|
| Hanson McClain Advisors | 2.00 | $3.000000 | 0% | Sep 2025 |
|
| TD Waterhouse Canada | 2.00 | $3.000000 | 0% | Sep 2025 |
|
| Dogwood Wealth Management | 1.00 | $1.000000 | 0% | Sep 2025 |
|
| Zrc Wealth Management | 1.00 | $2.000000 | 0% | Sep 2025 |
|
Who sold out of Galmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Jun 2025 | 23k | $43k |
| Cambridge Investment Research Advisors | Jun 2025 | 10k | $19k |
| UMA Financial Services | Jun 2025 | 23.00 | $43.000800 |
| Raymond James Financial | Jun 2025 | 12.00 | $21.999600 |